Bell Investment Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51
Closed -$662 1915
2025
Q1
$662 Sell
51
-39
-43% -$516 ﹤0.01% 1674
2024
Q4
$1.15K Sell
90
-21
-19% -$254 ﹤0.01% 1541
2024
Q3
$1.24K Sell
111
-44
-28% -$485 ﹤0.01% 1531
2024
Q2
$1.74K Hold
155
﹤0.01% 1420
2024
Q1
$1.92K Hold
155
﹤0.01% 1377
2023
Q4
$2.17K Hold
155
﹤0.01% 1297
2023
Q3
$2.29K Buy
155
+60
+63% +$844 ﹤0.01% 1198
2023
Q2
$1.23K Buy
95
+44
+86% +$501 ﹤0.01% 1525
2023
Q1
$501 Buy
+51
New +$544 ﹤0.01% 1828

Other funds holding DVAX

Bell Investment Advisors's DVAX Position: Q2 2025 in Review

Bell Investment Advisors sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 51 shares — an estimated $662 sold.

Bell Investment Advisors first reported a position in DVAX in Q1 2023 and held it in 9 quarters. The position peaked at $2.29K in Q3 2023. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Bell Investment Advisors reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 51 Dynavax Technologies shares in Q2 2025, an estimated $662.
  • Bell Investment Advisors first reported a position in Dynavax Technologies in Q1 2023 and held it in 9 quarters.
  • Bell Investment Advisors's Dynavax Technologies position peaked at $2.29K in Q3 2023.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Bell Investment Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.